FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma

Details 詳細情報について

• CRID

  1363388845932385408

• DOI

  10.1245/s10434-018-6512-8

• ISSN

  15344681

  10689265

• Web Site

  http://link.springer.com/article/10.1245/s10434-018-6512-8/fulltext.html

  http://link.springer.com/content/pdf/10.1245/s10434-018-6512-8.pdf

• Data Source

  • Crossref